Overview
Progressive epilepsy and/or ataxia with myoclonus as a major feature is not a single disease but rather a grouping term (now considered obsolete in classification systems) that was used to describe a collection of rare neurological conditions. These conditions share key features: seizures (epilepsy) that worsen over time, problems with coordination and balance (ataxia), and sudden, brief involuntary muscle jerks (myoclonus). This category historically included disorders such as Unverricht-Lundborg disease, Lafora disease, neuronal ceroid lipofuscinoses, sialidosis, and mitochondrial disorders like MERRF (myoclonic epilepsy with ragged red fibers), among others. Patients in this group typically experience a combination of worsening seizures, progressive difficulty walking and coordinating movements, and involuntary muscle twitches that can significantly interfere with daily activities. Over time, cognitive decline may also occur depending on the specific underlying condition. The age when symptoms begin, how quickly the disease progresses, and the overall outlook vary widely depending on which specific disorder is responsible. Because this is an umbrella grouping rather than a single disease, treatment depends entirely on identifying the specific underlying condition. In general, management focuses on controlling seizures with anti-epileptic medications, managing myoclonus, and providing physical and occupational therapy to maintain function. Some specific conditions within this group have targeted treatments, while others are managed symptomatically. Accurate genetic diagnosis is essential to guide treatment and provide families with information about what to expect.
Key symptoms:
Seizures that get worse over timeSudden involuntary muscle jerks (myoclonus)Problems with balance and coordinationDifficulty walkingUnsteady gaitTremorSlurred speechCognitive decline or learning difficultiesDifficulty with fine motor tasks like writingMuscle stiffness or spasticityVision problems in some formsSensitivity to light triggering seizuresProgressive loss of independenceEmotional and behavioral changes
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Progressive epilepsy and/or ataxia with myoclonus as a major feature.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Progressive epilepsy and/or ataxia with myoclonus as a major feature at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Progressive epilepsy and/or ataxia with myoclonus as a major feature.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Progressive epilepsy and/or ataxia with myoclonus as a major feature.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Progressive epilepsy and/or ataxia with myoclonus as a major feature.
Start the conversation →Latest news about OBSOLETE: Progressive epilepsy and/or ataxia with myoclonus as a major feature
No recent news articles for OBSOLETE: Progressive epilepsy and/or ataxia with myoclonus as a major feature.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What specific condition within this group do I or my child have, and how was it identified?,What is the expected course of this specific condition, and how quickly might symptoms progress?,Which anti-seizure medications are safest for this condition, and which ones should be avoided?,Are there any clinical trials or experimental treatments available for this specific diagnosis?,What therapies (physical, occupational, speech) should we start now to maintain function?,Should other family members be tested, and what is the chance of passing this to future children?,What emergency plan should we have in place for prolonged seizures?
Common questions about OBSOLETE: Progressive epilepsy and/or ataxia with myoclonus as a major feature
What is OBSOLETE: Progressive epilepsy and/or ataxia with myoclonus as a major feature?
Progressive epilepsy and/or ataxia with myoclonus as a major feature is not a single disease but rather a grouping term (now considered obsolete in classification systems) that was used to describe a collection of rare neurological conditions. These conditions share key features: seizures (epilepsy) that worsen over time, problems with coordination and balance (ataxia), and sudden, brief involuntary muscle jerks (myoclonus). This category historically included disorders such as Unverricht-Lundborg disease, Lafora disease, neuronal ceroid lipofuscinoses, sialidosis, and mitochondrial disorders